12289125 · Active · incorporated 6 years, 9 months ago · London
Biotech AI Biotech & Life Sciences Deep Tech Drug Discovery Series B+
Baseimmune develops next-generation active immunotherapies using computational design and protein engineering, focusing on mutation-proof vaccines.
See the complete cap table with every shareholder, founder tags, dilution across 14 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.